LEGN
NASDAQ
US
Legend Biotech Corporation - American Depositary Shares
$19,14
▲ +$0,09
(+0,47%)
Vol 1.2M
6
Skor Kualitas
fail
Pendapatan ✗
Laba Bersih ✗
>IPO ✗
Kap. Pasar
$4.0B
ROE
-23,4%
Margin
-26,4%
D/E
40,57
Beta
0,08
52W
$21–$45
Konsensus Wall Street
24 analis · Apr 20267
Beli Kuat
14
Beli
3
Tahan
0
Jual
0
Jual Kuat
87,5%
Peringkat Beli
Grafik Harga
Saham Serupa
FOLD
Amicus Therapeutics Inc
$4.4B
VKTX
Viking Therapeutics Inc
$4.0B
ACAD
ACADIA Pharmaceuticals Inc
P/E 17,3
$4.5B
SYRE
Spyre Therapeutics Inc
$2.5B
DNLI
Denali Therapeutics Inc
$2.6B
DYN
Dyne Therapeutics Inc
$3.2B
TNGX
Tango Therapeutics Inc
$1.2B
TWST
Twist Bioscience Corp
$1.9B
CPRX
Catalyst Pharmaceuticals Inc
P/E 13,2
$2.9B
Pendapatan
Tingkat beat: 20,0%
Laporan Berikutnya
Mei 11, 2026
Estimasi EPS: $-0,03
| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Mar 2026 | $-0,03 | — | — |
| Des 2025 | $-0,11 | $-0,16 | $-0,05 |
| Sep 2025 | $-0,09 | $-0,22 | $-0,13 |
| Jun 2025 | $-0,15 | $-0,68 | $-0,53 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Pendapatan | — | $186.5M | $195.1M | $255.1M | $272.3M | $306.4M |
| Laba Bersih | — | $26.3M | -$100.9M | -$125.4M | -$39.7M | -$30.8M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -30.9% | -30.9% | -30.9% | -30.9% | -23.4% | -23.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -49.2% | -40.8% | -40.8% | -40.8% | -26.4% | -26.4% |
| Gross Margin | 61.6% | 62.5% | 62.5% | 62.5% | 60.5% | 60.5% |
| D/E Ratio | 37.46 | 37.46 | 37.46 | 37.46 | 40.57 | 40.57 |
| Current Ratio | 4.71 | 4.71 | 4.71 | 4.71 | 2.86 | 2.86 |
Rasio Utama
ROA (TTM)
-14,4%
P/S (TTM)
4,42
P/B
5,7
EPS (TTM)
$-0,65
Pertumbuhan Pendapatan 3T
+108,9%
52W High
$45,30
52W Low
$21,19
$21,19
Rentang 52 Minggu
$45,30
Kesehatan Keuangan
Arus Kas Bebas
-$24.6M
Utang Bersih
-$488.2M
Kas
$901.9M
Total Utang
$413.7M
Per tanggal Des 31, 2025
Як LEGN виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка LEGN vs аналоги Biotechnology
P/E
—
▼
0%
di bawah
rekan
(18,8)
vs Rekan
vs Industri
Undervalued
P/S
4,4
▼
66%
di bawah
rekan
(12,9)
vs Rekan
vs Industri
Undervalued
P/B
5,7
▲
133%
di atas
rekan
(2,5)
vs Rekan
vs Industri
Overvalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,0%)
vs Rekan
vs Industri
Yield rendah
Прибутковість LEGN vs аналоги Biotechnology
ROE
-23,4%
▲
65%
di atas
rekan
(-67,3%)
vs Rekan
vs Industri
Tingkat atas
Net margin
-26,4%
▲
91%
di atas
rekan
(-286,8%)
vs Rekan
vs Industri
Di bawah rata-rata
Валова маржа
60,6%
▼
23%
di bawah
rekan
(78,6%)
vs Rekan
vs Industri
Lemah
ROA
-14,4%
▲
69%
di atas
rekan
(-46,7%)
vs Rekan
vs Industri
Tingkat atas
Фінансове здоровʼя LEGN vs аналоги Biotechnology
D/E ratio
40,6
▼
0%
di bawah
rekan
(0,0)
vs Rekan
vs Industri
Utang tinggi
Поточна ліквідність
2,9
▼
35%
di bawah
rekan
(4,4)
vs Rekan
vs Industri
Likuiditas rendah
Beta
0,1
▼
92%
di bawah
rekan
(1,0)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів LEGN
LEGN
Median rekan
Industri
LEGN прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
LEGN vs аналоги: ключові метрики
Pemegang Terbesar
Top 5: 26,47%FMR, LLC
13,12%
$407.7M
Suvretta Capital Management…
3,57%
$111.0M
Westfield Capital Managemen…
3,33%
$103.6M
HHLR Advisors, LTD
3,24%
$100.5M
Deerfield Management Compan…
3,21%
$99.7M
Per tanggal Des 31, 2025
Berita Terbaru
Belum ada berita terkait